Skip to content

Ultrasound-guided posterior ramus of the thorac-lumbar spinal nerve block for anesthesia and analgesia in lumbar surgery

Ultrasound-guided posterior ramus of the thorac-lumbar spinal nerve block for anesthesia and analgesia in lumbar surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023614
Enrollment
Unknown
Registered
2019-06-04
Start date
2019-06-30
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anesthesia and analgesia in lumbar surgery

Interventions

Group A:At the fracture site, a single injection of 20ml mixture (10ml 1% ropivacaine + 2ml iodohydrin + 8ml normal saline) was given to the posterior surface of one side of the transverse process of
Group B:At the fracture site, 6.7ml mixture (10ml 1% ropivacaine + 2ml iodohydrin + 8ml normal saline) was injected into the posterior surface of one side of transverse process of the vertebral body o
Group I:Routine general anesthesia without nerve block
Group II:According to the better nerve block scheme selected in the first part of the experiment, the posterior branch of thoracolumbar spinal nerve was blocked and general anesthesia was performed

Sponsors

Shanghai Sixth People's Hospital East Campus
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The American society of anesthesiologists (ASA) assessment is I to III; 2. Single segment lumbar open reduction and internal fixation; 3. Preoperative examination without obvious contraindication and history of mental disorders; 4. gave and signed the informed consent; 5. Aged 18 to 65 years.

Exclusion criteria

Exclusion criteria: 1. Patients who cannot cooperate; with local anesthetic and iodine allergy history; 2. Patients with multiple segmental lesions; 3. Comorbidity with severe osteoporosis or other bone metabolic diseases spinal fractures or other bone structure abnormalities; 4. Surgical site infection and previous surgical treatment of this site; 5. Infection in the intervertebral space or elsewhere; 6. Patients with severe hepatorenal insufficiency and uncorrected hypoproteinemia; 7. People who are known to be allergic to sufentanil or other opioids, aspirin, iodine and local anesthetics; 8. Patients with bronchial asthma with respiratory depression and myasthenia gravis with active peptic ulcer or gastrointestinal bleeding and ischemic heart disease; 9. Drug addict.

Design outcomes

Primary

MeasureTime frame
The visual analogue scale of group I and group II at postoperative 4 h, 8 h, 12 h, 24 h, 48 h when resting and activities;

Secondary

MeasureTime frame
Duration of onset of nerve block;Block completion time;Fentanyl dosage;Postoperative analgesic effect satisfaction;Number of postoperative remedial analgesia cases;Postoperative adverse reactions;

Countries

China

Contacts

Public ContactWang Aizhong

Shanghai Sixth People's Hospital East Campus

w19680420@sohu.com+86 13817029752

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026